Jun 14,2021 02:43 PM
India continues to report a sustained slide in the daily new COVID cases.
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||677.10||72.90||162,494.96||327.39||1.11||3,119.04||104.36|
|Divis Laboratories Ltd||4,388.05||59.58||116,462.39||487.93||0.46||1,718.39||349.25|
|Dr Reddys Laboratories Ltd||5,461.35||41.54||90,816.62||311.50||0.46||3,313.50||1,020.99|
|Cadila Healthcare Ltd||655.40||41.16||67,075.62||464.70||0.53||1,949.70||124.49|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Headquartered in Mumbai, India, Alkem Laboratories Limited is a leading Indian pharmaceutical company with global operations. The company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. With a portfolio of more than 700 b... More
Reports by alkem-laboratories-ltd-share-price
Jun 14, 2021 11:26 PM
The company’s consolidated revenue in the period stood at Rs1,918.92cr, up 3.22% yoy and 15.66% qoq.
25 May 2021
14 May 2021
Alkem Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company is s... More
05 Feb 2021
11 Feb 2021
Pursuant to Reg 30 read with Reg 33 and Reg 42 of the SEBI (LODR) Regulations, 2015 , the Board of D... More
05 Feb 2021
27 Jan 2021
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is ... More